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Aims: To compare the impact of trigeminal neuralgia (TN) and painful post-traumatic 
trigeminal neuropathy (PPTTN) on psychological function and health-related quality of life 
(HRQoL) using a comprehensive quantitative assessment. Methods: This was a comparative 
cross-sectional study. Ninety-seven patients diagnosed with PPTTN and 40 patients with TN 
who sought treatment at an Orofacial Pain Clinic completed standardised self-report measures of 
pain intensity, neuropathic symptoms, pain self-efficacy, mood, and generic and oral HRQoL 
indicators. Differences between PPTTN and TN groups were tested,and associations between 
pain severity, psychological function and HRQoL examined. Results: The majority of PPTTN 
(66%) and TN patients (80%) were affected by orofacial pain. Pain attacks were more frequent in 
TN (71%) than PPTTN (28%) patients while numbness more common in PPTTN (51%) than TN 
(12%). Pain intensity was higher in TN for intermittent and affective pain dimensions. Both 
PPTTN and TN had a significant but comparable impact on patients’ oral HRQoL. The burden of 
condition on overall health was significantly more pronounced in patients with TN than PPTTN, 
with differences evident in mobility and self-care domains. There was a trend showing that more 
TN (54%) than PPTTN (36%) patients reported signs of depression, but clinically significant 
anxiety was comparably high in both groups (34-39%). Anxiety and pain-self efficacy were 
closely related to oral and general health status in both groups. Conclusions: Both TN and 
PPTTN are associated with significant psychosocial burden and reduced HRQoL, indicating a 
need to develop effective treatments for neuropathic orofacial pain that target functional 
restoration.  
Keywords: trigeminal neuralgia; post-traumatic trigeminal neuropathy; orofacial pain; 




Chronic orofacial pain is multidimensional in nature, commonly involving a neuropathic pain 
(NP) component. The International Association for the Study of Pain (IASP) defines NP as “pain 
arising as a direct consequence of a lesion or disease affecting the somatosensory system”1 
Neuropathic pain of the orofacial region may be episodic, such as trigeminal neuralgias (TN), or 
continuous, which includes painful post-traumatic trigeminal neuropathy (PPTTN). Long-
standing neuropathic orofacial pain may lead to significant changes in the individual’s 
psychological status, level of daily functioning and social interaction.2 Accordingly, the 
relationships between NP conditions, such as TN and PPTTN, and psychological morbidities 
have increasingly become of interest to researchers.3 
Trigeminal neuralgia (TN), although rare, is one of the well-known causes of severe 
orofacial pain. TN is defined by the International Association for the Study of Pain (IASP) as “a 
sudden, usually unilateral, severe, brief, stabbing recurrent pain in the distribution of one or more 
branches of the fifth cranial nerve”.4 Data from GP practices based in the United Kingdom drew 
an incidence of 8 per 10,000 people per year.5 
According to The International Classification of Headache Disorders (ICHD)6,  two types 
of classical trigeminal neuralgia are identified. The first type is purely paroxysmal without 
persistent background facial pain (classical trigeminal neuralgia, purely paroxysmal). It is 
usually responsive, at least initially, to pharmacotherapy (especially carbamazepine or 
oxcarbazepine). The second type (classical trigeminal neuralgia with concomitant continuous 
pain) is characterized by persistent background facial pain of moderate intensity in the affected 
area, which is less likely to be triggered by innocuous stimuli.6 Central sensitization may account 
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for the persistent facial pain. Additionally, symptomatic TN may occur secondary to the presence 
of an intracranial lesion compressing the trigeminal nerve at its root entry zone or secondary to 
multiple sclerosis.7, 8 
The neuropathic pain in TN patients is often excruciating, leading to severe distress 
which often causes anxiety, depression, and reduced quality of life.9-12 It may lead to even 
suicide in some cases.13 TN patients usually seek health care from many providers with different 
specialties until proper diagnosis and management can be achieved. Dentists and physicians tend 
to first consider more common conditions likely to occur in the facial region (like toothache and 
temporomandibular disorders) rather than TN which is a relatively rare condition.14 Initial 
misdiagnosis may lead to unnecessary interventions in many patients, especially unneeded dental 
restorative and surgical procedures, which may add further to their suffering.15 
Another prominent cause of orofacial NP is iatrogenic trigeminal nerve injuries (TNI), 
which may occur in relation to dental or oral surgical procedures, and often lead to painful post-
traumatic trigeminal neuropathy (PPTTN). This damage may happen during implant placement, 
root canal treatment, orthognathic surgery, local anaesthetic injections and surgical removal of 
mandibular third molars.16 The incidence of painful neuropathy following TNIs is around 3-
5%,17 and a key feature of PPTTN is the presence of continuous burning and/or shooting pain in 
an area of the trigeminal nerve distribution with a clear history of trauma. Clinically, there may 
be positive and/or negative changes in the neurological profile, which are the marking 
characteristic of PPTTN.18 
Renton and Yilmaz19 have demonstrated the functional disability that patients with 
trigeminal nerve injuries may suffer from. This can include problems with speaking, eating, 
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drinking, make up application, and shaving, all of which lead to dramatic effects on personal and 
social lives. Smith and colleagues’3 study of patients with TNI indicated the increased risk of 
psychological dysfunction in patients with PPTTN as well as poor oral health-specific and 
overall quality of life. 
As chronic orofacial pain extends over time, the psychosocial consequences of pain may 
become themselves etiological factors in the maintenance and enhancement of associated 
symptoms. Psychosocial factors are now believed to play an important role in the maintenance 
and amplification of the pain experience, and can affect the coping capabilities of the patient and 
the impairment of daily life activities.20, 21 Consequently, it is recognized that psychological 
factors associated with chronic orofacial pain need to be urgently addressed during diagnosis and 
treatment planning to achieve proper pain management.22 
Distinguishing between TN and trigeminal neuropathy arising from (dental) trauma is 
important from both a diagnostic and management perspective.18 Different orofacial pain 
conditions are often associated with varying degrees of psychological distress and (impaired) 
quality of life, as well as differences in disease perception and ways of coping with the painful 
disorder.9 Previous studies focussing on the psychosocial burden of patients with different types 
of orofacial pain have tended to compare neuropathic and non-neuropathic conditions,9 and 
where both TNI and TN patients have been considered they tend to be grouped together2 or the 
samples were very small.23 Comparisons of TN with other neuropathic disorders are rare. One 
recent study reported more severe pain intensity in TN than patients with burning mouth 
syndrome (BMS), although the psychosocial impact of these conditions was comparable.24 The 
aim of this study was to evaluate the psychosocial impact of TN and TNI using a comprehensive 
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quantitative assessment, and to explore the relationship between neuropathic pain 
symptomatology, psychological function, and quality of life in TN and PPTTN patients.  
Materials and Methods 
Design 
This was a comparative cross-sectional study, which evaluated the symptomatology and 
psychosocial impact of TN and PPTTN in patients who consecutively attended an orofacial Pain 
Clinic in South London (Dental Institute, King’s College Hospital, London) during the period 
from January 2016 to August 2017. Data collection was done at the point of referral to the 
specialist centre. Written informed consent was obtained from all patients providing permission 
for their anonymised data to be used for research purposes. Ethical approval for the study was 
provided by the London– Dulwich Research Ethics Committee (REC reference 15/LO/1108).  
Participants 
Overall, 200 patients with a diagnosis of TN or PPTTN attended the service during the study 
periods under consideration for each (January 2016-August 2017 for TN patients, January 2016-
February 2017 for PPTTN patients). This included 141 patients with PPTTN, 58 with TN, and 
one patient with both PPTTN and TN diagnoses. The latter was excluded from comparative 
analyses. Two patients with TN secondary to other causes with known psychiatric morbidity, 
specifically, patients who had multiple sclerosis (MS) before the onset of their TN, were 
excluded also, while one patient with PPTTN linked to bruxism was excluded. Bruxism is a 
parafunctional habit which is likely to induce painful TMJ dysfunction, but is not identified as a 
possible etiology for PPTTN. So, to avoid any symptom overlap which could affect the final 
results, we decided to exclude this case. All patients were examined thoroughly by specialized 
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pain consultants and referred to a neurologist for validation of the diagnosis where appropriate. 
Magnetic resonance imaging was used when indicated for exclusion of underlying causative 
lesions and detection of potential neurovascular compression of the trigeminal nerve. Patients 
were diagnosed according to the criteria of The International Classification of Headache 
Disorders, 3rd edition (beta version).6 The assessment protocol of trigeminal neuropathy used in 
the clinic has been published previously.25 No patient was included in the study if they were 
affected by other potentially confounding facial pain conditions (other than headache or 
migraine) or severe mental illness. Demographic and clinical information were extracted from 
patients’ records, including data concerning trigeminal nerve divisions involved in orofacial NP 
condition, side of the face affected, sensory deficits identified in clinical assessment (PPTTN), 
presence of migraines/headaches, and whether patients had other (bodily) chronic pain or any 
comorbid medical conditions. 
Measures and Instruments 
Participants of both groups were asked to complete a number of self-report, standardized 
questionnaires commonly used to measure pain experience, (oral) health-related quality of life 
(HRQoL) and psychological function in patients with chronic pain.3 Questionnaires were 
administered at patients’ first clinic appointment either manually using hard copies or 
electronically using IMPARTS (an initiative funded by King’s Health Partners to ‘integrate 
mental and physical healthcare in research, training and clinical services’).  
Affective and Health Function Questionnaires 
Depression was assessed using the 9-item Patient Health Questionnaire (PHQ-9),26 a measure 
that assesses core diagnostic areas underlying clinical depression on a 9-item scale. Each item is 
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rated on a 4-point frequency scale ranging from 0 (‘not at all’) to 3 (‘nearly every day’), with an 
overall score ranging from 0 to 27. Mild, moderate, moderately severe depression, and severe 
depression are indicated by scores of 5, 10, 15, and 20, respectively. The PHQ-9 has been 
validated in patients with a broad range of physical health problems, including chronic pain.27 
Anxious mood and behaviour was assessed with the 7-item Generalized Anxiety Disorder 
(GAD-7).28 Response options for each item range from 0 (‘not at all’) to 3 (‘nearly every day’), 
with a total score range of 0 to 21. Higher scores indicate more severe anxiety (disorder); a score 
of 8 or more indicates clinically significant levels of anxiety.28 The GAD-7 has been 
recommended for the assessment of anxiety in patients with orofacial pain.29 
Oral health-related quality of life (OHRQoL) was assessed with the Oral Health Impact 
Profile (OHIP-14), a widely used questionnaire assessing the oral health domains of functional 
limitation, physical pain, psychological discomfort, physical disability, psychological disability, 
social disability and handicap.30 The measure consists of 14 items, each scored on an ordinal 
frequency scale as follows: 0 = ‘never’; 1 = ‘hardly ever’; 2 = ‘occasionally’; 3 = ‘fairly often’; 4 
= ‘very often’. Summary variables computed for the OHIP-14 were an overall severity score of 
oral HRQoL impairment, calculated as the sum of all ordinal responses (range = 0 to 56), and an 
extent score determined by the number of items with ‘fairly often’ or ‘very often’ responses. The 
psychometric properties of the OHIP-14 are generally good.22, 31 
HRQOL was measured using the EQ-5D-5L, a generic health status questionnaire that 
consists of five dimensions: mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression. Using a 5-point ordinal scale (‘no problems’, ‘slight problems’, ‘moderate 
problems’, ‘severe problems’ and extreme problems; coded from 0 to 4), respondents were asked 
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to select the level which best matched their health for each domain. For each patient, an overall 
health state valuation (EQ-Health), ranging from -0.285 for extreme problems in all domains to 
1.000 for no problems in any domain, was calculated according to a value set recently developed 
for England populations.32 Patients also indicated their self-rated health on a 20-cm vertical 
visual analog scale (EQ-VAS) with worst (0) and best health (100) they could imagine as scale 
anchors.33 The EQ-5D-5L has shown sufficient convergent validity to be used with patients with 
persistent orofacial pain.34 
Pain and Pain-Related Function Questionnaires 
Patients who reported experiencing orofacial pain at the time of consultation were asked to 
complete measures gauging pain experience and pain-related function.  
The sensory, affective, and evaluative qualities of pain were measured using the Short-Form 
McGill Pain Questionnaire – 2 (SF-MPQ-2), a 22-item revised version of the SF-MPQ that uses a 11-
point numeric rating scale (NRS) on all items and includes symptoms relevant to neuropathic pain 
(Dworkin et al., 2009).  An overall score is determined by the mean of all 22 items, with higher scores 
indicative of more severe symptoms. Four subscales have been established based on pain descriptors: 
continuous, intermittent, neuropathic, and affective. Subscales are scored by calculating the mean of the 
relevant items. There is support for the construct validity, convergent validity and reliability of the SF-
MPQ-2 across many chronic pain conditions.35, 36 
Patients’ current pain  level and their average and strongest pain over the last month was 
measured using the PainDetect 11-point NRS.37 The quality and intensity of specific neuropathic 
symptoms, specifically, burning, prickling, allodynia, attacks, thermal sensitivity, numbness and pressure 
were gauged from the sensory descriptors of the PainDetect Questionnaire. For each symptom, patients 
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rated the perceived severity on a 6-point scale (0 = ‘never’; 1 = ‘hardly noticed’; 2 = ‘slightly’; 3 = 
‘moderately’; 4 = ‘strongly’; 5 =‘very strongly’). 
The 10-item Pain Self-Efficacy Questionnaire (PSEQ) was used to assess the confidence TN and 
PPTTN patients (currently) had in performing activities across different areas (e.g., work, leisure, 
household chores) while experiencing pain.38 Each item response is scored on a 7-point ordinal scale 
ranging from 0  (not at all confident) to 6 (completely confident). Total scores are determined by the sum 
of all item responses and range from 0 to 60. Lower scores reflect a patient’s strong focus on their pain 
whereas higher scores suggest strong self-efficacy beliefs. The PSEQ has good test–retest reliability and 
internal consistency39 and has been used in previous research with TNI patients.3 
Across standardised measures, scores for missing items were imputed from the mean of 
the other scale items in cases where 10% or less of items were missing (above 10% and the entire 
scale was considered missing). The only exception to this was for the SFMPQ-2, where if there 
was one missing item within a subscale, SF-MPQ-2 subscale scores were computed as the 
average of answered items, and a total score was only calculated in cases where not more than 
one item was missing on any subscale. 
Statistical Analysis 
Comparisons between PPTTN and TN patient subgroups on sociodemographic and clinical 
characteristics, and pain-related, psychosocial and HRQoL indicators were measured using t-test, 
analysis of covariance (ANCOVA) and 2. In instances when continuous data distributions were 
clearly non-normal, bootstrapping (bias-corrected and accelerated; based on 2000 bootstrap 
samples) was employed to calculate 95% confidence intervals of mean difference and associated 
P values. Where group comparisons of categorical variables controlled for another variable, 
binary logistic regression was employed. To evaluate the association between HRQoL indicators 
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and relevant variables, such as measures relating to pain, mood and sociodemographic and 
clinical characteristics, Pearson correlation coefficients and Spearman’s Rho were calculated 
according to the distributional properties of the data. The criterion for statistical significance was 
set at P < .05, with no adjustments for multiple comparisons given the descriptive nature of the 
study. All statistical analyses were completed with the Statistical Package for the Social 
Sciences, Release 24.0 (SPSS, IBM). 
Results 
One hundred and thirty-seven (69.9%) patients completed one or more questionnaires and were 
included in analyses; 97/137 (69.3%) PPTTN patients and 40/56 (71.4%; P = .768) TN patients. 
There was a trend suggesting questionnaires were more likely to be completed by older patients 
(completers, mean [M] = 52.92, SD = 14.57, non-completers, M = 48.54, SD = 14.61; P = .056). 
But questionnaire completion was not related to gender or clinical features of condition such as 
duration, trigeminal nerve division affected, number of divisions affected, side of face affected, 
or presence of headaches/migraines (for all comparisons between completers and non-
completers, P > .14).  
The sociodemographic and clinical characteristics of PPTTN and TN patients completing 
measures are provided in Table 1. The majority (70% overall) were female. The TN patients 
were, on average, more than 10 years older than patients with PPTTN. Chronicity of condition 
(time since onset > 6 months) was high in both patient groups, but duration was significantly 
longer for TN patients. PPTTN was most common in the mandibular division, while TN affected 
both the maxillary and mandibular divisions with comparable frequency. PPTTN was 
predominantly localized in one division or another. In contrast, almost half of the TN patients 
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had more than one division affected. Symptoms were lateralized approximately equally in both 
patient groups although a small number of PPTTN patients were affected bilaterally. Almost a 
quarter of TN patients also suffered from headaches or migraines; this was marginally 
significantly higher than the rate in patients with PPTTN. TN patients were also more likely than 
PPTTN patients to have one or more comorbid medical conditions.     
TN without persistent pain was diagnosed in 21 (52.5%) of the 40 patients; TN with 
persistent pain was diagnosed in 19 (47.5%) patients. No precipitant factor was reported in 80% 
(32) of TN cases. In the remaining cases, a range of (dental) events were recalled by the patients 
as an initiator(e.g., dental extraction, endodontic treatment, car accident); however, the 
symptoms, examination and course of the disorder pointed clearly to TN, rather than PPTTN or 
any other orofacial condition. The aetiology of PPTTN varied widely. PPTTN was sustained 
during third molar surgery for just under 30% of patients’ (TMS; 29 or 29.9%), while in 4 
patients, PPTTN was precipitated by extraction of another tooth. PPTTN emerged after repeated 
extractions or interventions in 16 (16.5%) patients, following implant in 11 (11.3%) patients, and 
as a result of local anaesthesia in 8 (8.2%) patients. A variety of other causes were identified in 
16 (28.6%) patients, including  endodontic treatment (2), accidental injury (3), ear/nasal surgery 
(2) infection (1), and osteotomy (1).The cause was unknown or not recorded in 13 (13.4%) 
patients.  
[Insert Table 1 about here]      
Data from clinical assessment (qualitative testing) of sensory symptoms in PPTTN was 
available for 88 patients. Twenty-three (26.1%) presented with hypoesthesia alone; hypoesthesia 
was accompanied by paraesthesia in 2 patients, dysesthesia in one patient, allodynia in 2 patients 
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and a combination of one or more of these symptoms in 6 patients. Paraesthesia alone was 
observed in 24 patients (27.3%), dysesthesia alone in 4 (4.5%) patients, hyperalgesia alone in 3 
patients and allodynia alone in 11 (12.5%) patients. Paraesthesia and dysesthesia was observed in 
2 patients, paraesthesia and allodynia in 2 patients, dysesthesia and hyperalgesia in one patient, 
dysesthesia and allodynia in 2 patients and hyperalgesia and allodynia in 2 patients. Two patients 
had paraesthesia, hyperalgesia and allodynia while another had paraesthesia, dysesthesia and 
allodynia. 
Affective and Health Function 
HRQoL and mood data for the PPTTN and TN samples are shown in Table 2. TN patients 
tended to score higher on the PHQ-9 than PPTTN patients but differences were not significant. 
More than half (15 or 53.6%) of patients with TN showed some signs of depression (PHQ-9 ≥ 5), 
compared with approximately a third of PPTTN patients (33 or 35.9%; P = .094), while 
moderately severe/severe depression (PHQ-9 ≥ 15) was evident in a fifth of TN patients (5 or 
17.9%) and a tenth of PPTTN patients (10 or 10.9%; P = .328). Anxiety levels were highly 
comparable between participant groups; GAD-7 scores indicated that almost 40% (15 or 38.5%) 
of TN patients and over a third (33 or 34.4%; P = .653) of PPTTN patients experienced clinically 
significant levels of anxiety (GAD-7 ≥ 8).   
[Insert Table 2 about here]   
PPTTN and TN had a marked but comparable effect on patients’ OHRQoL. Mean 
severity scores on the OHIP-14 were higher than the 90th percentile value for the UK dentate 
population, which ranges from 10-17 across age groups and gender,40 and significantly greater 
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than those observed in a study of patients assessed one week after (successfully) undergoing 
third molar surgery41 (M = 8.6, SD = 7.2, P < .001). 
While both groups’ mean EQ-5D-5L health state valuation scores were less than (EQ-5D-
3L) norms observed in age-matched healthy UK populations (which across ten-year age cohorts 
from 25-75 years range from 0.93 to 0.78),42 overall health was significantly poorer in patients 
with TN than PPTTN. The difference was only marginally significant after accounting for age 
and presence of comorbid medical condition (P = .086), however, suggesting worse HRQoL in 
TN patients was partly attributable to their older age and greater likelihood of comorbid illness. 
Nevertheless, post-hoc group comparisons focussed on patients’ EQ-5D-5L profile (Fig 1) 
showed, after controlling for age and comorbid medical condition, significantly worse mobility 
(P = .032) and self-care (P = .027) in TN patients compared with PPTTN patients. 
Pain/discomfort and mood disturbances were domains most affected for both groups, however. 
[Insert Fig 1 about here]   
Severity of Pain and Sensory Symptoms 
The majority of PPTTN (64 or 66.0%) and TN patients (32 or 80.0%; P = .103) indicated that 
they were affected by pain at the time of their consultation and (consequently) completed pain-
specific measures (Table 3). Unsurprisingly, overall, these patients reported worse quality of life 
as evidenced by elevated OHIP-14 scores (M = 31.81, SD = 14.57 versus M = 19.64, SD = 
12.52, P < .001) and lower EQ-Health values (M = 0.5806, SD = 0.2629 versus M = 0.8537, SD 
= 0.2081, P < .001).   
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For those patients completing pain-specific measures, pain severity varied widely across 
patients. There was a marked difference between diagnostic groups in 4-week strongest pain 
intensity, however, with TN patients reporting pain at almost ceiling levels. Notably, almost 
three-quarters of TN patients reported pain that was, on average, severe (i.e., ≥ 743; 19 or 73.1%) 
compared with a little more than half (33 or 55.9%; P = .135) of patients with PPTTN. Overall, 
severity of pain as measured by the SFMPQ-2 was numerically (but not significantly) greater in 
TN than PPTTN patients. However, examination of the subscales revealed a marked (highly 
significant) elevation in TN patients’ intermittent and affective pain in contrast with continuous 
and neuropathic pain domains, which were approximately equivalent between TN and PPTTN 
groups (Fig 2). Self-efficacy for coping with pain was moderate in patients with no difference 
according to orofacial condition. 
[Insert Table 3 about here] 
    [Insert Fig 2 about here]     
The frequency of neuropathic sensory disturbances that were regarded as clinically 
relevant (i.e., ‘strongly’ or ‘very strongly’) for PPTTN and TN participants, gauged from the 
PainDetect Questionnaire, is shown in Fig 3. More than half of patients with PPTTN reported 
clinically relevant numbness, a proportion that was significantly greater than that reported by TN 
patients. In contrast, (electric shock) attacks were a defining feature of TN patients’ pain, with 
just under three-quarters of patients indicating clinically relevant levels compared with 
approximately 30% of PPTTN patients. Clinically relevant cold/hot pain was also more frequent 
in TN patients but differences with PPTTN patients were not significant (P = .183). 
[Insert Fig 3 about here]    
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Relationships between Pain Characteristics, Affective Function and HRQoL in PPTTN and 
TN groups 
Table 4 shows correlations between generic and oral health-specific QoL indicators and SFMPQ-
2 subscales and mood and pain self-efficacy measures for each patient group. In the PPTTN 
group, across all pain measures, save neuropathic pain for EQ-Health, there were significant 
moderate associations with HRQoL. Both anxiety and self-efficacy were also moderately related 
to HRQoL, while PHQ-9 scores were significantly correlated with HRQoL but the magnitude of 
the association was smaller. In contrast, no pain measure was significantly correlated with TN 
patients’ oral health, although neuropathic pain was marginally significant (P = .065), and only 
intermittent pain showed a strong relationship with TN patients’ EQ-Health scores. However, 
both self-efficacy and anxiety were linked with TN patients’ HRQoL. Notably, for both groups 
age, gender, duration of condition and presence of headaches/migraines, or comorbid medical 
condition were not significantly related to either HRQoL score (for all associations, P > .10). 
Patients with bodily chronic pain (PPTTN M = 0.5409 SD = 0.2982; TN M = 0.4441, SD = 
0.3522) showed worse EQ-Health scores than those without (PPTTN M =0.7210 SD = 0.2504; 
TN M = 0.6250, SD = 0.2657), although the difference was only significant in the PPTTN group 
(P = .021) and not the TN group, where small numbers likely precluded a significant effect (P = 
.145).  TN patients with persistent pain  had significantly poorer EQ-Health Scores (M = 0.4692, 
SD = 0.2751) than did TN patients without persistent pain (M = .6827, SD = 0.2839; P = .028) 
but there was no difference in OHIP-14 totals (P = .279).   




To our knowledge, this is the first study directly comparing both the neuropathic 
symptomatology and psychosocial impact of trigeminal neuralgia to that of (painful) 
posttraumatic trigeminal neuropathy, using a comprehensive quantitative psychosocial 
assessment. While OHRQoL and psychological function were comparable between groups, the 
results showed more severe intermittent and affective pain in TN patients and poorer general 
health which was partly attributable to their older age and higher prevalence of comorbid 
medical conditions. All aspects of pain were significantly associated with HRQoL in PPTTN 
patients only, while anxiety and pain-self efficacy was related to oral and general health in both 
groups.   
Demographics and Clinical Characteristics 
Women were over-represented in both PPTTN and TN samples, concurring with several clinical 
studies and a recent review of population-based studies (TN) that showed greater prevalence in 
women for both conditions.11, 18, 19, 44-46 The reason for the elevated risk of TTN and TN in 
women remains unclear, although it may be related to gender, the differential manner in which 
the brains of women respond to the affective dimensions of pain,47 which was elevated in TN 
patients in this study. Also, women are more likely to seek medical care in general and, more 
specifically, seek advice regarding pain.48 TN patients were significantly older than patients with 
PPTTN, consistent with the findings of previous comparative studies18, 23 and those across 
individual studies of these conditions.11, 19, 45, 46 While the incidence of TN is known to increase 
with age, peaking between 50 and 60 years,11, 44 the onset age for PPTTN varies more widely 
according to the cause of injury.19 
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The etiology of PPTTN in the present study varied widely with the greatest percentage 
attributed to third molar surgery (TMS; 30%). However, this represents a lower value than the 
percentage of TMS- related PPTTN in previous studies.3, 19, 48 When trigeminal nerve injuries do 
occur as a complication of dental/oral surgical procedures, they usually affect the lingual and/or 
inferior alveolar branches of the mandibular division and affect the left or right sides at equal 
rates.46 In line with this, PPTTN was most common in the mandibular division of the trigeminal 
nerve, with approximately equal lateralization, although a small percentage had symptoms on 
both sides. In contrast, consistent with the somatology relationship of sensory fibres in the 
trigeminal nerve and previous investigations of TN populations, TN affected both the maxillary 
and mandibular divisions with a predominance of right-sided symptoms.11, 45, 46 Bilateral 
symptoms were not observed in any TN patients in the present study; bilateral TN appears to be 
rare except for cases where TN is caused by multiple sclerosis.18, 49 
We observed in our TN sample that almost half had TN with concomitant pain, a similar 
proportion to the Maarbjerg et al.45 cohort (49%) but considerably more than in the recent 
Zakrzewska et al.11 study. It is possible the high rate of TN with concomitant persistent pain in 
our cohort relates to the referral process, as the clinic has specialist headache neurology input to 
the assessment and management of patients. Almost a quarter of TN patients also suffered from 
headaches or migraines; this was significantly higher than in patients with PPTTN, where it was 
uncommon. Headaches disorders are frequently observed in TN; one recent study identified 
headache in aquarter of patients and migraines or migraines with tension-type headache in one-
fifth.11 Interestingly, Lin and colleagues recently proposed migraine as a previously unidentified 
risk factor for TN, suggesting the presence of a linked underlying mechanism.50 Comorbid 
medical conditions were also more frequent in TN patients, a likely consequence of their older 
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age and the association of TN with various systemic diseases such as multiple sclerosis, 
hypertension and cardiovascular disease.51, 52 
Pain Severity and Sensory Symptoms 
Most TN and PPTTN patients experienced substantial pain. A minority of patients did not report 
(problematic) pain at the time of consultation, consistent with previous studies indicating that, at 
least for some patients presenting in specialist care clinics, TNI may be clinically reflected in a 
loss of function (anesthesia, hypoesthesia) without pain,3, 19 and that frequently in TN, there are 
changes in sensory quality over the course of the disease.11, 53 
There was a tendency for TN patients to report higher levels of pain than patients with 
PPTTN, most obviously when considering “strongest pain”, which was at ceiling levels. A 
previous study comparing these patient groups also observed higher ‘typical’ pain levels in TN.18 
TN is considered one of the most painful pain experiences that a patient can report and still no 
universal treatment is available which can definitely and completely relieve this excruciating, 
unpredictable pain.54 However, examination of patients’ pain experience using the SFMPQ-2 
revealed significantly elevated scores for TN patients (relative to PPTTN patients) on 
intermittent and affective pain subscales only. Intermittent pain attacks are a cardinal sign of 
TN4, 15 and less common after TNI,19 so the observed difference is not surprising. But the data 
also indicate that patients with TN may have greater pain-related affective distress than patients 
with PPTTN. Zakrzewska and colleagues11 observed that more than half of TN patients attending 
their clinic choose a word from “fearful,” “frightful,” or “terrifying” to describe their pain, 
attributing high pain catastrophising in this group to unpredictability of the pain attacks. 
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Interestingly, continuous pain scores were comparable between patient groups, reflecting 
inclusion in the study of a significant number of TN patients with concomitant persistent pain. 
Clinically significant levels of neuropathic symptoms in TN and PPTTN patients were 
highly similar for burning, prickling, allodynia and pressure (ranging from a quarter to a half of 
patients across symptoms), reflecting the overlap in symptomatology of the two conditions. More 
than 50% of patients with PPTTN reported clinically relevant numbness, however, in contrast to 
just 11% of TN patients. This is consistent with the nature of TNIs, where patients 
predominantly suffer from neurosensory loss of function in the area supplied by the severed 
nerve in the form of hypoesthesia or anesthesia.46, 55, 56 In contrast, “electric shock” attacks were 
the defining prominent feature of TN patients’ neuropathic symptomatology, affecting almost 
three-quarters of patients, consistent with the known characteristics of TN.6, 18, 23 
Affective and Health Function 
In both TN and PPTTN, patients face limitations in their daily life activities in addition to the 
overwhelming chronic pain experience. This often leads to psychosocial distress and reduced 
quality of life.11, 48, 57 Our results provide further evidence of the close association between 
chronic neuropathic orofacial pain, mood disturbance and poor oral and general health.  
The burden of orofacial pain condition on overall health was significantly more 
pronounced in patients with TN compared with PPTTN. Our scores are consistent with those 
indicating poor quality of life in previous (separate) studies of populations with PPTTN and TN 
using EQ-5D.3, 10 There are two likely explanations for the observed differences. First, the TN 
patients were older, and as a group more likely to have a comorbid medical illness and 
(numerically) experience bodily chronic pain, both of which can impair health, especially 
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Mobility and Self-care domains for which between-group differences were most marked. 
Second, differences may be attributable to higher intermittent pain levels in the TN group. 
Intermittent pain was moderately associated with poor HRQoL in both groups, and the only pain 
dimension linked with HRQoL in the TN group. In a qualitative study, Allsop et al.15 found TN 
patients’ quality of life was specifically related to fear of pain recurring suddenly and lack of 
psychological support, in addition to other management-related factors such as delay in diagnosis 
and side effects of medications. Zakrzewska and colleagues11 have also emphasised the 
debilitating effects of fear associated with unpredictability of intermittent pain in TN and lack of 
confidence in dealing with these attacks, and how it results in high pain catastrophizing levels. 
Despite more severe (intermittent and affective) pain in TN patients, PPTTN and TN 
patient groups evidenced comparably impaired OHRQoL. It is well established that altered 
sensation in the orofacial region as a result of TNI can interfere with a number of functions  
including eating, drinking, kissing, make up application, shaving, and tooth brushing, all of 
which affect patients’ quality of life.19, 46 One recent study found that enjoying social contact with 
other people, the ability to eat and enjoy food and maintaining an emotional state without 
irritability were the most affected aspects of health function affected in a group of TNI patients.58 
Similar functional problems are also experienced by TN patients.6, 59 But interestingly, whereas - 
in line with previous studies of patients with PPTTN - neuropathic pain severity showed a 
moderate-to-strong relationship with oral health,3 no aspect of pain was reliably linked with 
OHRQoL in TN patients, suggesting that the extent of functional impairment for activities that 
involve the face are not necessarily related to the frequency or intensity of TN pain attacks.  
The disability experienced by PPTTN and TN patients is consistent with the high levels 
of anxiety and depression evidenced by both groups. Observed levels of anxiety and depression 
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were in line with those shown in other (separate) studies of patients with PPTTN and TN,3, 11, 60 
indicating mood disturbances, particularly anxiety disorders, are prevalent in these conditions. 
TN patients may be at greater risk of depression than patients with PPTTN, broadly consistent 
with the elevated levels of affective pain distress we observed in this group as well as studies 
showing a close relationship between pain severity and depression in patients with neuropathic 
orofacial pain.3, 12 
The findings of affective and psychological dysfunction in both patient groups, which 
was severe in 15-20% of cases, supports calls for the routine use of holistic, multidisciplinary 
approaches for pain management in PPTTN and TN patients.11, 61 Significantly, anxiety and pain 
self-efficacy were reliably associated with oral and general health in both groups. In TN patients, 
psychological function was more closely related to oral health status than any measure of pain 
and only intermittent pain better correlated with general health, indicating that mental health 
status of these patients is closely linked with pain-related disability. Galli and colleagues62 found 
that (after controlling for pain severity) beliefs about illness, particularly that pain could have 
serious consequences on one’s life and low personal control, negatively impacted on treatment 
outcomes in a group of patients with orofacial pain that included individuals with TN. In patients 
with temporomandibular muscle and joint disorders, both worry about pain and depression have 
been shown to contribute to the progression of chronic pain disability.21 More generally, neural 
markers for fear and anxiety which exacerbate chronic pain have been identified.63 As such, 
psychological-based interventions (e.g., cognitive behavioural therapy) that target psychosocial 
components in patients with TN and PPTTN, such as pain-related anxiety, illness beliefs, and 
affective dimensions of orofacial pain, may usefully complement aspects of treatment concerning  




The study was cross-sectional and, as such, pain severity and psychosocial constructs were 
assessed at a single time point only not allowing specification of the nature of identified 
relationships between pain, psychosocial factors and quality of life. Further, the psychological 
and health status of patients prior to nerve injury or onset of TN is unclear. A recent retrospective 
study of patients with orofacial neuropathic pain found a history of chronic stress and 
psychological/psychiatric illness in 37% of cases,64 suggesting a high rate of psychological 
dysfunction prior to onset of orofacial pain. Additionally, the study involved a population of 
patients who attended a specialist national clinic and may not be representative of the wider 
population of patients with TNI and TN (who may not be as severely affected). Also, not all 
patients attending the clinic completed measures. However, this was not related to orofacial 
condition or clinical profile suggesting the samples were representative of referred patients. The 
sample size of TN patients was relatively small (compared with the PPTTN sample) and 
heterogeneous, which may have contributed to the inability to detect statistically significant 
effects on some outcomes, precluded multivariate analysis of factors associated with oral and 
general HRQoL (identified from bivariate analyses), and did not readily allow comparisons of 
important subgroups. Additionally, as previously noted, TN patients were older and more often 
had a comorbid medical illness than patients with PPTTN, complicating comparisons of affective 
and health function. Finally, there was no correction for multiple group comparisons, raising the 




Both TN and PPTTN are associated with a significant psychosocial burden and reduced quality 
of life. While oral health is affected equally in TN and PPTTN, reflecting the loss of function for 
activities that involve the face associated with both conditions, TN has a more marked impact on 
overall health in comparison to PPTTN. Neuropathic pain intensity is higher in TN than PPTTN, 
notably for aspects closely related to pain attacks that characterise the former, such as strongest 
pain endured and intermittent and affective pain dimensions. TN patients also appear to be at 
greater risk of depression, although clinically significant anxiety is comparably high in both 
groups, evident in up to 40% of patients. The substantial burden of illness observed here, in 
addition to the close associations between anxiety and pain self-efficacy and oral and general 
HRQoL in both groups, suggest a need for psychological support to be integrated into the 
management programmes of both conditions to help patients cope better with their chronic 
disorder and improve efficacy of treatment. 
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Fig 1 EQ-5D-5L profile (percentage reporting problems in each dimension) of 
painful post-traumatic trigeminal neuropathy (PPTTN) and trigeminal neuralgia (TN) 
patients. Note: Data labels represent percentages; for Mobility, Self-care, Usual 
activities and Anxiety/Depression dimensions, TN n = 39; * Indicates significant 
differences between groups after controlling for age (P < .05). 
Fig 2 Mean scores on Short Form McGill Pain Questionnaire – 2 (SFMPQ-2) 
subscales (0-10). Note: PPTTN = painful post-traumatic trigeminal neuropathy; TN = 
Trigeminal neuralgia; Data labels represent mean values; Error bars represent the 
standard error of the mean; n values for subscales are variable due to missing responses 
on some SFMPQ-2 items; * Indicates significant differences between groups (*P < .05; 
**P < .001).  
Fig 3 Frequency (percentage of patients) indicating clinically relevant problems 
(i.e., score > 3) on dimensions of neuropathic pain in the PainDetect Questionnaire. 
Note: PPTTN = painful post-traumatic trigeminal neuropathy; TN = trigeminal 
neuralgia; Data labels represent percentages; n values for dimensions are variable due to 
missing responses on some PainDetect Questionnaire items; ** Indicates significant 
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Table 1. Demographic and Clinical Characteristics of Patients with Painful Post-Traumatic 
Neuropathy (PPTTN) and Trigeminal Neuralgia (TN). Numbers represent frequency (percentage) 
unless otherwise stated.  
Variable PPTTN  
(n = 97) 
TN  




Sociodemographic    
    Gender: Female 70 (72.2%) 26 (65.0%) .405 
Age (Mean [SD]) 49.4 (13.8) 61.3 (13.1) <.001 
Clinical Characteristic    
Duration (Mths;Median[IQR]) 13.0 (5.0-36.0) 34.0 (12.0-78.0) .039 
>6 months 61 (67.8) 31 (93.9) .002 
Division affected 
 
   
Ophthalmic (V1) 0 (0.0) 2 (5.0)  
Maxillary (V2) 23 (24.2) 9 (22.5)  
Mandibular (V3) 64 (67.4) 11 (27.5)  
Ophthalmic and Maxillary (V1, V2) 
 
 
1 (1.1) 4 (10.0)  
Maxillary and Mandibular (V2, V3) 
 
 
3 (3.2) 12 (30.0)  
Ophthalmic, Maxillary and Mandibular (V1,V2,V3) 
 
 
3 (3.2) 2 (5.0) <.001 
More than one division affected 8 (8.4) 18 (45.0) <.001 
Side affected 
 
   
Left 45 (46.9) 17 (42.5)  
Right 41 (42.7) 23 (57.5)  
Both 10 (10.4)  0 (0.0) .061 
Headaches or Migraines 11 (11.3) 9 (23.1) .080 
Other (Bodily) Chronic Pain 13 (13.4) 10 (25.0) .099 
Comorbid Medical Condition(s) 25 (25.8) 18 (45.0) .027 
    
Note: IQR = inter-quartile range; Co-medical conditions included (but were not limited to) hypertension, diabetes, 
hypothyroidism, multiple sclerosis, epilepsy, hiatus hernia, cardiovascular disease, and/or malignancy; there was a small 
number of missing data on some variables stated percentages and means refer to participants with data available for 






Table 2. Affective Function and Health-Related Quality of Life (HRQoL) in Painful Post-Traumatic 
Neuropathy (PPTTN) and Trigeminal Neuralgia (TN) Patients. 
 PPTTN TN PPTTN vs TN 





       
Mood       
PHQ-9 (0-27) 92 4.74 (6.54) 28 6.89 (6.76) -2.15 (-5.17,0.64) .145 
GAD-7 (0-21) 96 6.09 (5.95) 39 5.97 (5.65) 0.12 (-2.08,2.32) .915 
       
HRQoL measures       
OHIP Severity (0-56) 97 28.57 (15.02) 38 27.61 (15.21) 0.96 (-4.82,6.56) .739 
OHIP Extent (0-14) 97 5.92 (4.33) 38 5.87 (4.36) 0.49 (-1.49,1.59) .863 




EQ VAS (0-100) 97 69.78 (22.94) 39 64.00 (23.41) 5.78 (-2.53,14.48) .211 
        Note: n values for questionnaires are variable due to a small number of patients not completing all measures; P values were 
calculated using independent group t-tests; PHQ-9 = Patient Health Questionnaire – 9; GAD-7 = Generalized Anxiety 
Disorder - 7; OHIP = Oral Health Impact Profile; EQ Health = EQ-5D-5L health state evaluation; EQ VAS = current 











Table 3. Pain and Pain-Self Efficacy in Painful Post-Traumatic Neuropathy (PPTTN) and Trigeminal 
Neuralgia (TN) Patients. 
 
 PPTTN TN PPTTN vs TN  





       
Pain (PDQ; 0-10)       
Pain now  59 5.19 (2.71) 26 4.31 (3.16)  0.88 (-0.46,2.31) 0.222 
Strongest pain  59 7.22 (2.67) 26 8.50 (1.86)  -1.28 (-2.23,-0.25) 0.016 
Average pain  59 6.03 (2.73) 26 7.04 (2.34) -1.01 (-2.23,0.22) 0.107 
SFMPQ-2 (Total; 0-10) 59 3.18 (2.25) 19 3.89 (2.05) -0.71 (-1.87,0.45) 0.228 
PSEQ (0-60) 60 34.55 (15.28) 27 35.56 (15.76) -1.01 (-8.12,6.10) 0.779 
        Note: n values for questionnaires are variable due to a small number of patients not completing all measures; P values were 
calculated using independent group t-tests; PDQ = PainDetect Questionnaire, SFMPQ-2 = Short Form McGill Pain 














Table 4. Associations Between HRQoL, Pain Characteristics and Affective 
Function in Painful Post-Traumatic Neuropathy (PPTTN; n = 97) and 
Trigeminal Neuralgia (TN; n = 40) Groups. 
 PPTTN TN 
Questionnaire OHIP Severity EQ Health OHIP Severity EQ Health 
SFMPQ-2      
Continuous 0.48** -0.49**  0.03   0.05 
Intermittent 0.52** -0.47**  0.34  -0.61* 
Neuropathic 0.67**      -0.20  0.39  0.03 
Affective 0.44** -0.43**  0.24 -0.09 
PHQ-9 0.30** -0.39**  0.22 -0.18 
GAD-7 0.42** -0.57**    0.45*   -0.33* 
PSEQ (0-60)           -0.45**  0.56**     -0.61**    0.44* 
        Note: Values presented are Pearson r or Spearman rho (according to distribution of 
correlated variables); n values for SFMPQ-2 subscales are maximum of 61 for PPTTN and 
23 for TN; OHIP = Oral Health Impact Profile; EQ Health = EQ-5D-5L health state 
evaluation;  SFMPQ-2 = Short Form McGill Pain Questionnaire – 2;  PHQ-9 = Patient 
Health Questionnaire – 9; GAD-7 = Generalized Anxiety Disorder - 7; PSEQ = Pain Self-
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